Prognosis

Oxford, AstraZeneca Begin Advanced Trials of Covid Vaccine

AstraZeneca's September Target for 30M Vaccine Doses Is 'Achievable,' Says CEO

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By John Lauerman

May 22, 2020 at 7:47 AM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

The University of Oxford and AstraZeneca Plc have begun recruiting more than 10,000 subjects for advanced human studies of one of the world’s fastest-moving experimental Covid-19 vaccines.